173 related articles for article (PubMed ID: 32044580)
1. Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells.
Petreni A; Bonardi A; Lomelino C; Osman SM; ALOthman ZA; Eldehna WM; El-Haggar R; McKenna R; Nocentini A; Supuran CT
Eur J Med Chem; 2020 Mar; 190():112112. PubMed ID: 32044580
[TBL] [Abstract][Full Text] [Related]
2. Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms.
Eldehna WM; Taghour MS; Al-Warhi T; Nocentini A; Elbadawi MM; Mahdy HA; Abdelrahman MA; Alotaibi OJ; Aljaeed N; Elimam DM; Afarinkia K; Abdel-Aziz HA; Supuran CT
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):531-541. PubMed ID: 34991416
[TBL] [Abstract][Full Text] [Related]
3. Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and
Abdelrahman MA; Eldehna WM; Nocentini A; Ibrahim HS; Almahli H; Abdel-Aziz HA; Abou-Seri SM; Supuran CT
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):298-305. PubMed ID: 31809607
[TBL] [Abstract][Full Text] [Related]
4. Effective Anticancer Potential of a New Sulfonamide as a Carbonic Anhydrase IX Inhibitor Against Aggressive Tumors.
Koyuncu I; Temiz E; Güler EM; Durgun M; Yuksekdag O; Giovannuzzi S; Supuran CT
ChemMedChem; 2024 May; 19(9):e202300680. PubMed ID: 38323458
[TBL] [Abstract][Full Text] [Related]
5. Tailored Tetrasubstituted Imidazole Carrying the Benzenesulfonamide Fragments as Selective Human Carbonic Anhydrase IX/XII Inhibitors.
Taher ES; Marzouk AA; Abd-Allah WH; Giovannuzzi S; Ibrahim TS; Supuran CT; El Hamd MA; El-Behairy MF
ChemMedChem; 2024 May; 19(10):e202400004. PubMed ID: 38356418
[TBL] [Abstract][Full Text] [Related]
6. Development of Novel Quinoline-Based Sulfonamides as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors.
Shaldam M; Nocentini A; Elsayed ZM; Ibrahim TM; Salem R; El-Domany RA; Capasso C; Supuran CT; Eldehna WM
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681794
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and in vitro evaluation of novel thiazole-coumarin hybrids as selective and potent human carbonic anhydrase IX and XII inhibitors.
Singh P; Nerella SG; Swain B; Angeli A; Ullah Q; Supuran CT; Arifuddin M
Int J Biol Macromol; 2024 May; 268(Pt 1):131548. PubMed ID: 38642682
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of carbonic anhydrase-IX by sulphonamide derivatives induces pH and reactive oxygen species-mediated apoptosis in cervical cancer HeLa cells.
Koyuncu I; Gonel A; Kocyigit A; Temiz E; Durgun M; Supuran CT
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1137-1149. PubMed ID: 30001631
[TBL] [Abstract][Full Text] [Related]
9. 6-Aminocoumarin oxime-ether/sulfonamides as selective hCA IX and XII inhibitors: Synthesis, evaluation, and molecular dynamics studies.
Ghouse SM; Sinha K; Bonardi A; Pawar G; Malasala S; Danaboina S; Mohammed A; Yaddanapudi VM; Supuran CT; Nanduri S
Arch Pharm (Weinheim); 2023 Oct; 356(10):e2300316. PubMed ID: 37495909
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the antiproliferative and apoptotic roles of sulfonamide carbonic anhydrase IX inhibitors in HeLa cancer cell line.
Koyuncu I; Gonel A; Durgun M; Kocyigit A; Yuksekdag O; Supuran CT
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):75-86. PubMed ID: 30362386
[TBL] [Abstract][Full Text] [Related]
11. 2H-chromene and 7H-furo-chromene derivatives selectively inhibit tumour associated human carbonic anhydrase IX and XII isoforms.
Sequeira L; Distinto S; Meleddu R; Gaspari M; Angeli A; Cottiglia F; Secci D; Onali A; Sanna E; Borges F; Uriarte E; Alcaro S; Supuran CT; Maccioni E
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2270183. PubMed ID: 37870190
[TBL] [Abstract][Full Text] [Related]
12. Discovery and Mechanistic Studies of Dual-Target Hits for Carbonic Anhydrase IX and VEGFR-2 as Potential Agents for Solid Tumors: X-ray,
Hefny SM; El-Moselhy TF; El-Din N; Giovannuzzi S; Bin Traiki T; Vaali-Mohammed MA; El-Dessouki AM; Yamaguchi K; Sugiura M; Shaldam MA; Supuran CT; Abdulla MH; Eldehna WM; Tawfik HO
J Med Chem; 2024 May; 67(9):7406-7430. PubMed ID: 38642371
[TBL] [Abstract][Full Text] [Related]
13. Saccharin: a lead compound for structure-based drug design of carbonic anhydrase IX inhibitors.
Mahon BP; Hendon AM; Driscoll JM; Rankin GM; Poulsen SA; Supuran CT; McKenna R
Bioorg Med Chem; 2015 Feb; 23(4):849-54. PubMed ID: 25614109
[TBL] [Abstract][Full Text] [Related]
14. Discovery of non-sulfonamide carbonic anhydrase IX inhibitors through structure-based virtual screening.
Cheng T; Wang N; Wen R; Wang S; Zhang H; Cheng M
Phys Chem Chem Phys; 2024 Mar; 26(11):8767-8774. PubMed ID: 38420672
[TBL] [Abstract][Full Text] [Related]
15. First studies on tumor associated carbonic anhydrases IX and XII monoclonal antibodies conjugated to small molecule inhibitors.
Testa C; Papini AM; Zeidler R; Vullo D; Carta F; Supuran CT; Rovero P
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):592-596. PubMed ID: 35057692
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of diaryl urea molecules with and without sulfonamide group on Carbonic anhydrase IX and XII inhibition and its consequence on breast cancer cells.
Debnath J; Keshamasetthy D; Combs J; Leon K; Vullo D; Chatterjee A; McKenna R; Supuran CT
Bioorg Chem; 2024 Apr; 145():107192. PubMed ID: 38382393
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents.
Krasavin M; Kalinin S; Sharonova T; Supuran CT
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1555-1561. PubMed ID: 32746643
[TBL] [Abstract][Full Text] [Related]
18. A potentiated cooperation of carbonic anhydrase IX and histone deacetylase inhibitors against cancer.
Ruzzolini J; Laurenzana A; Andreucci E; Peppicelli S; Bianchini F; Carta F; Supuran CT; Romanelli MN; Nediani C; Calorini L
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):391-397. PubMed ID: 31865754
[TBL] [Abstract][Full Text] [Related]
19. Identification of thienopyrimidine derivatives tethered with sulfonamide and other moieties as carbonic anhydrase inhibitors: Design, synthesis and anti-proliferative activity.
Higazy S; Samir N; El-Khouly A; Giovannuzzi S; Begines P; Gaber HM; Supuran CT; Abouzid KAM
Bioorg Chem; 2024 Mar; 144():107089. PubMed ID: 38237393
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and mechanism study of coumarin-sulfonamide derivatives as carbonic anhydrase IX inhibitors with anticancer activity.
Lv Q; Zhang J; Cai J; Chen L; Liang J; Zhang T; Lin J; Chen R; Zhang Z; Guo P; Hong Y; Pan L; Ji H
Chem Biol Interact; 2024 Apr; 393():110947. PubMed ID: 38479716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
